UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 16, 2013

QUICK-MED TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

Nevada
000-27545
65-0797243
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

902 NW 4th Street
Gainesville, Florida
32607
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code (352) 379-0611
 
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
 
Item 8.01
Other Events
 
On April 12, 2013, Quick-Med Technologies, Inc. (the “Company”) issued a press release announcing the engagement of Match Point Partners LLC, as the Company’s investment banker. A copy of the press release is filed as Exhibit 99.1 to this Report.
 
Item 9.01
Financial Statements and Exhibits
 
99.1
 
 
 

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
QUICK-MED TECHNOLOGIES, INC.
 
(Registrant)
   
Date:  April 16, 2013
 
 
/s/  Paul Jenssen
 
Paul Jenssen, Chief Financial Officer